Sangamo Therapeutics (LTS:0R1D) Accounts Payable & Accrued Expense : $33.94 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sangamo Therapeutics Accounts Payable & Accrued Expense?

Sangamo Therapeutics's quarterly accounts payable & accrued expense increased from Sep. 2023 ($29.69 Mil) to Dec. 2023 ($34.22 Mil) but then declined from Dec. 2023 ($34.22 Mil) to Mar. 2024 ($33.94 Mil).

Sangamo Therapeutics's annual accounts payable & accrued expense increased from Dec. 2021 ($17.31 Mil) to Dec. 2022 ($34.30 Mil) but then declined from Dec. 2022 ($34.30 Mil) to Dec. 2023 ($34.22 Mil).

Sangamo Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sangamo Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangamo Therapeutics Accounts Payable & Accrued Expense Chart

Sangamo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

14.34

22.48

17.31

34.30

34.22

Sangamo Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															35.32	33.80	29.69	34.22	33.94

Sangamo Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sangamo Therapeutics (LTS:0R1D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SGMO:USA GBY:Germany

Address

7000 Marina Boulevard, Brisbane, CA, USA, 94005

Website

https://www.sangamo.com

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Sangamo Therapeutics (LTS:0R1D) Headlines

No Headlines